45 LIBERTY BLVD., MALVERN, PA
Asset Purchase Agreement with Biossil Inc. for Dismutase Mimetic Assets
Galera Therapeutics Enters Asset Purchase Agreement with Biossil Inc.
Material Contracts
News, Material Contracts
Amended material disclosure
Shareholder votes
Completes acquisition of Nova Pharmaceuticals, Investor Presentation
News
Q2
Q1
Q3
Notice of Late Filing for Quarterly Report
FY 2023
Notice of Exempt Offering of Securities
Prospectus Filed Pursuant to Rule 425
Registration of Securities
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload
Deregistration Letter